These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2877227)

  • 1. Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment?
    Calne DB; Eisen A; McGeer E; Spencer P
    Lancet; 1986 Nov; 2(8515):1067-70. PubMed ID: 2877227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are age-related neurodegenerative diseases linked with various types of magnesium depletion?
    Durlach J; Bac P; Durlach V; Durlach A; Bara M; Guiet-Bara A
    Magnes Res; 1997 Dec; 10(4):339-53. PubMed ID: 9513930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of idiopathic parkinsonism.
    Uitti RJ; Calne DB
    Eur Neurol; 1993; 33 Suppl 1():6-23. PubMed ID: 8375434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postencephalitic Parkinson's disease, amyotrophic lateral sclerosis on Guam and influenza revisited: focusing on neurofibrillary tangles and the trail of tau.
    Maurizi CP
    Med Hypotheses; 2002 Mar; 58(3):198-202. PubMed ID: 12018970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aetiology of Parkinson's disease.
    Calne DB; Langston JW
    Lancet; 1983 Dec 24-31; 2(8365-66):1457-9. PubMed ID: 6140548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
    Hoogendijk WJ; Pool CW; Troost D; van Zwieten E; Swaab DF
    Brain; 1995 Feb; 118 ( Pt 1)():131-43. PubMed ID: 7894999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aging immune system in Alzheimer's and Parkinson's diseases.
    Heavener KS; Bradshaw EM
    Semin Immunopathol; 2022 Sep; 44(5):649-657. PubMed ID: 35505128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region-specific vulnerability in neurodegeneration: lessons from normal ageing.
    Pandya VA; Patani R
    Ageing Res Rev; 2021 May; 67():101311. PubMed ID: 33639280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease.
    Doty RL; Perl DP; Steele JC; Chen KM; Pierce JD; Reyes P; Kurland LT
    Neurology; 1991 May; 41(5 Suppl 2):77-80; discussion 80-1. PubMed ID: 2041598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
    Calne DB; Eisen A
    Adv Neurol; 1990; 53():355-60. PubMed ID: 2239477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.
    Buée-Scherrer V; Buée L; Hof PR; Leveugle B; Gilles C; Loerzel AJ; Perl DP; Delacourte A
    Am J Pathol; 1995 Apr; 146(4):924-32. PubMed ID: 7717459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P and neurodegenerative disorders. A speculative review.
    Barker R
    Neuropeptides; 1991 Oct; 20(2):73-8. PubMed ID: 1724684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeking environmental causes of neurodegenerative disease and envisioning primary prevention.
    Spencer PS; Palmer VS; Kisby GE
    Neurotoxicology; 2016 Sep; 56():269-283. PubMed ID: 27050202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor neuron disease: changing population patterns and clues for etiology.
    Kondo K
    Adv Neurol; 1978; 19():509-43. PubMed ID: 369333
    [No Abstract]   [Full Text] [Related]  

  • 16. Review: Axon pathology in age-related neurodegenerative disorders.
    Adalbert R; Coleman MP
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):90-108. PubMed ID: 23046254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines.
    Robbins JH; Otsuka F; Tarone RE; Polinsky RJ; Brumback RA; Nee LE
    J Neurol Neurosurg Psychiatry; 1985 Sep; 48(9):916-23. PubMed ID: 3876409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.
    Ballard PA; Tetrud JW; Langston JW
    Neurology; 1985 Jul; 35(7):949-56. PubMed ID: 3874373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of obesity on neurodegenerative diseases.
    Mazon JN; de Mello AH; Ferreira GK; Rezin GT
    Life Sci; 2017 Aug; 182():22-28. PubMed ID: 28583368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of the striatal efferents and nigral dopaminergic neurons in parkinsonism-dementia complex on Guam in comparison with those in Parkinson's and Alzheimer's diseases.
    Goto S; Hirano A; Matsumoto S
    Ann Neurol; 1990 May; 27(5):520-7. PubMed ID: 1694418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.